- Report
- January 2021
- 63 Pages
India
From €3798EUR$3,995USD£3,191GBP
- Report
- June 2022
Global
€2847EUR$2,995USD£2,392GBP
- Report
- June 2022
- 211 Pages
Global
€3798EUR$3,995USD£3,191GBP
- Report
- June 2020
- 191 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- March 2020
China
From €7600EUR$7,995USD£6,385GBP
- Report
- January 2025
- 89 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2024
- 102 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 105 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- November 2023
- 94 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2022
- 94 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- November 2024
- 147 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €4749EUR$4,995USD£3,989GBP
- Report
- October 2024
- 51 Pages
Japan
From €4749EUR$4,995USD£3,989GBP
- Report
- January 2023
- 32 Pages
Mexico
From €2847EUR$2,995USD£2,392GBP
- Report
- January 2023
- 32 Pages
Japan
From €2847EUR$2,995USD£2,392GBP
- Report
- January 2023
- 32 Pages
Italy
From €2847EUR$2,995USD£2,392GBP
- Report
- January 2023
- 32 Pages
France
From €2847EUR$2,995USD£2,392GBP
- Report
- January 2023
- 32 Pages
China
From €2847EUR$2,995USD£2,392GBP
- Report
- January 2023
- 99 Pages
India, Russia, Brazil, ... India, Russia, Brazil, China
From €3798EUR$3,995USD£3,191GBP
- Report
- January 2023
- 32 Pages
Brazil
From €2847EUR$2,995USD£2,392GBP

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more